<DOC>
	<DOCNO>NCT01628211</DOCNO>
	<brief_summary>The purpose study evaluate whether second-look laparoscopy , follow peritonectomy , hyperthermic intraperitoneal chemotherapy ( HIPEC ) systemic chemotherapy case peritoneal carcinosis , improve overall survival patient radical resection mucinous colorectal cancer .</brief_summary>
	<brief_title>Second Look Laparoscopy Colorectal Cancer</brief_title>
	<detailed_description>Patients enter study radical resection mucinous colorectal cancer , reevaluate CT scan 6 month . Patients evidence disease randomize receive either standard follow , second look laparoscopy evaluate peritoneal carcinosis . After laparoscopy , patient peritoneal carcinosis continue standard follow . Patients peritoneal carcinosis diagnose laparoscopy treat accord peritoneal carcinosis index ( PCI ) . For patient PCI &gt; 20 , systemic chemotherapy give accord Italian Association Medical Oncology ( AIOM ) guideline . Patients PCI &lt; 20 undergo peritonectomy receive intravenous chemotherapy immediately follow HIPEC .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Histologic diagnosis colorectal adenocarcinoma Mucinous histotype Stage IIII Radical ( R0 ) surgical resection primary tumor CT scan contrast show evidence disease recurrence 6 month primary surgery Age ≥ 18 ≤ 65 year Performance Status ECOG ≤1 Normal hepatic , renal hematologic function Adjuvant chemotherapy permit Signed inform consent Residual disease surgical resection primary tumor Distant metastasis Active systemic infection Chronic cardiovascular illness would contraindicate abdominal dilatation pneumoperitoneum Concomitant previous malignancy 5 year surgical resection primary tumor ( except adequately treat nonmelanoma skin cancer situ cervical cancer ) Pregnancy lactation Refusal incapability provide informed consent Impossibility comply study schedule followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hyperthermic chemotherapy</keyword>
	<keyword>intraperitoneal chemotherapy</keyword>
	<keyword>second-look laparoscopy</keyword>
	<keyword>peritoneal carcinosis</keyword>
	<keyword>mucinous colorectal cancer</keyword>
</DOC>